mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.8 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.8 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.013 |
0.8 |